Discover 3,079 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,079
Active & Responsive
Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
for
Endometriosis
Location: 1 recruiting location
Sponsor: Mclean Hospital
Sex: Female
Age: 21+
Code: NCT06477406
Phase2, Recruiting
Active & Responsive
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
for
Bipolar Disorder
Location: 1 recruiting location
Sponsor: Mclean Hospital
Sex: All
Age: 18 - 65
Code: NCT05457465
Phase2, Recruiting
Active & Responsive
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia
for
Alzheimer Disease, Anxiety, Agitation,Psychomotor
Location: 1 recruiting location
Sponsor: Mclean Hospital
Sex: All
Age: 55 - 70+
Code: NCT04075435
Early_phase1, Recruiting
Active & Responsive
PAIN: a Project Assessing the Impact of a Novel Cannabinoid Product
for
Chronic Pain
Location: 1 recruiting location
Sponsor: Staci Gruber, Ph.D.
Sex: All
Age: 21+
Code: NCT03984565
Phase2, Recruiting
Active & Responsive
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
for
Metastatic Non Small Cell Lung Cancer
Location: 32 recruiting locations
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT05555732
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: 120 recruiting locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
Active & Responsive
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
for
Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative
Location: 12 recruiting locations
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04468061
Phase2, Recruiting
Active & Responsive
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: 76 recruiting locations
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase2, Phase3, Recruiting
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: 54 recruiting locations
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
Blood Flow Restriction Training After Patellar INStability